Agnew K L, Ruchlemer R, Catovsky D, Matutes E, Bunker C B
Department of Dermatology The Royal Marsden Hospital, London SW3 6JJ, U.K.
Br J Dermatol. 2004 Jun;150(6):1129-35. doi: 10.1111/j.1365-2133.2004.05982.x.
Chronic lymphocytic leukaemia (CLL) is a malignancy characterized by clonal expansion of B lymphocytes with distinct morphology and immunophenotype. The dermatological literature relating to CLL is sparse. A global descriptive survey of a large number of CLL patients has not previously been published.
To report the spectrum of dermatological conditions seen in a large series of CLL patients.
Skin complications in patients with established CLL were identified retrospectively from clinical and photographic records, principally a database of over 750 consecutive cases. These events were classified, enumerated and compared.
Forty patients with 125 skin manifestations were identified and studied. Forty-one manifestations had documented clinical or histological atypia. In 21 of these 41 complications there had been no prior immunosuppressive therapy. We observed that cutaneous malignancies frequently presented atypically both clinically and histologically. There were 18 patients with 56 instances of basal cell carcinoma (BCC) or squamous cell carcinoma (SCC), and clinical atypia was more common with SCC than with BCC. Other cutaneous findings included varicella zoster (n = 6), leukaemia cutis (n = 3), acute graft-versus-host disease (n = 5), cutaneous drug eruptions (n = 9), multiple warts (n = 3), herpes simplex (n = 3), cutaneous T-cell lymphoma (n = 2), eosinophilic folliculitis (n = 2), malignant melanoma (n = 2) and Merkel cell tumour (n = 2).
We have identified a range of dermatological conditions in CLL patients, with a tendency to atypical presentations. The atypia was independent of prior chemotherapy.
慢性淋巴细胞白血病(CLL)是一种以具有独特形态和免疫表型的B淋巴细胞克隆性扩增为特征的恶性肿瘤。与CLL相关的皮肤病学文献稀少。此前尚未发表过对大量CLL患者的全面描述性调查。
报告一大系列CLL患者中所见的皮肤病谱。
从临床和照片记录中,主要是一个超过750例连续病例的数据库中,回顾性识别已确诊CLL患者的皮肤并发症。对这些事件进行分类、计数和比较。
确定并研究了40例有125种皮肤表现的患者。41种表现有记录在案的临床或组织学非典型性。在这41种并发症中的21种中,之前没有进行过免疫抑制治疗。我们观察到皮肤恶性肿瘤在临床和组织学上经常表现为非典型。有18例患者出现56例基底细胞癌(BCC)或鳞状细胞癌(SCC),SCC的临床非典型性比BCC更常见。其他皮肤表现包括水痘带状疱疹(n = 6)、皮肤白血病(n = 3)、急性移植物抗宿主病(n = 5)、药物性皮疹(n = 9)、多发性疣(n = 3)、单纯疱疹(n = 3)、皮肤T细胞淋巴瘤(n = 2)、嗜酸性毛囊炎(n = 2)、恶性黑色素瘤(n = 2)和默克尔细胞肿瘤(n = 2)。
我们已经确定了CLL患者中的一系列皮肤病,且有非典型表现的倾向。这种非典型性与先前的化疗无关。